Decoding Alzheimer's disease at the cellular level reveals promising combination therapy.

Alzheimer's disease (AD) has long resisted effective treatments due to its pathological heterogeneity and cell-type-specific regulatory changes. In this issue of Cell, Li et al. leverage single-cell RNA sequencing and drug repurposing to propose a pr…

Preview only. Read the full abstract at the source